Project Grant R03AI177172
- This Project Grant award of $392,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports a research program at Arizona State University (ASU) focused on improving the understanding of cross-species viral transmission from wild mammals to humans. The key objectives of the five-year project are to: 1) develop automated tools to curate and maintain up-to-date taxonomic data on mammal and virus species, 2) test...
- Grant Award Summary Colorado State University received a $174,488 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on March 3, 2026, with completion targeted for June 11, 2027. The research project investigates the transmission dynamics and fitness of reemerging St. Louis Encephalitis Virus (SLEV) in mosquito vectors and West Nile Virus (WNV) in native and immune avian...
- Federal Project Grant Award Summary Virginia Polytechnic Institute & State University (Virginia Tech) received a $611,861 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2030. The research project investigates chromosomal rearrangements in Aedes aegypti mosquitoes, the primary vector for dengue and Zika fever transmission. The funded...
- This $600,000 Project Grant award from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (CFDA 10.310) aims to address the critical shortage of veterinary entomologists and provide entomological training to support the livestock industry. The 4-year program will be led by the University of Tennessee and involve collaborative research teams at the University of Georgia, Kansas State University, and Texas...
- Grant Award Summary The University of North Carolina at Greensboro received a $727,079 Project Grant (1R01AI180067-01A1) from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 10, 2025, with completion targeted for August 31, 2030. Under the direction of Principal Investigator Gideon Wasserberg, this research initiative investigates the behavioral, microbial, and chemical ecology of sand fly...
- This Project Grant award of $651,084, made by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to determine how microbes influence the response of their mosquito host to climate change, with a focus on the impacts on Hawaiian honeycreepers, an endangered bird species. The research aims to: Clarify the landscape-scale population dynamics of the mosquito vector Culex quinquefasciatus and its microbiome across an elevational gradient in Hawaii....
- Federal Grant Award Summary Boston University Medical Campus received a $449,625 Project Grant award dated July 8, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The two-year project, concluding July 7, 2027, focuses on developing novel research infrastructure and scientific understanding of arthropod-borne virus (ABV) transmission mechanisms. The primary deliverable is the development of an...
- Federal Grant Award Summary The Connecticut Agricultural Experiment Station received a $152,527 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 4, 2025, through July 31, 2027. This award supports research to elucidate the mechanisms of mosquito basement membrane (BM) repair and the implications for within-mosquito virus dynamics. The research will investigate...
- This $300,000 Project Grant, awarded by the USDA's National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (CFDA 10.310) program, will support the development of a sensitive, high-throughput multiplex diagnostic assay to simultaneously detect six major tick-borne pathogens, including Anaplasma, Borrelia, Ehrlichia, Rickettsia, Babesia, and Theileria. This assay will leverage barcoded magnetic bead technology to rapidly identify the causative agents of...
- This $120,000 Project Grant awarded by the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (CFDA 10.310) supports a study on Culicoides biting midges and their role in transmitting viral diseases like bluetongue virus and epizootic hemorrhagic disease virus to wild and domestic ruminants in Arkansas. The 2-year study will involve blood meal analysis to determine host-associations of Culicoides species collected across the state, as well...
DEFINING THE VIROSPHERE OF NEGLECTED HEMATOPHAGOUS ARTHROPODS - PROJECT SUMMARY HEMATOPHAGOUS ARTHROPODS TRANSMIT NUMEROUS VIRUSES, MANY OF WHICH ARE SERIOUS HUMAN PATHOGENS. TO COMBAT THE GROWING PUBLIC HEALTH IMPACT OF ARTHROPOD-TRANSMITTED VIRUSES, MANY METAGENOMICS STUDIES HAVE BEEN PERFORMED TO CHARACTERIZE THE ARTHROPOD VIROME. THE IMPORTANCE OF PROACTIVE VIRUS DISCOVERY CANNOT BE UNDERSTATED BECAUSE IT ALLOWS RISK ASSESSMENTS TO BE PERFORMED AND VIRAL DIAGNOSTIC ASSAYS AND CONTROL STRATEGIES TO BE DEVELOPED BEFORE VIRUS SPILLOVER OCCURS. MOST METAGENOMICS STUDIES DESIGNED TO IDENTIFY NOVEL ARTHROPOD- ASSOCIATED VIRUSES HAVE FOCUSED ON MOSQUITOES, WITH OTHER HEMATOPHAGOUS ARTHROPODS BEING LARGELY NEGLECTED. ANOTHER LIMITATION OF MANY PREVIOUS STUDIES IS THAT VIRUS ISOLATION WAS NOT ATTEMPTED, WITH NEWLY DISCOVERED VIRUSES KNOWN ONLY FROM SEQUENCE DATA, WHICH HAS IMPEDED THEIR PHENOTYPIC AND SEROLOGICAL CHARACTERIZATION. THE OVERALL GOAL OF THIS GRANT APPLICATION IS TO DEFINE THE VIROSPHERE OF UNDERSTUDIED HEMATOPHAGOUS ARTHROPODS AND TO IDENTIFY AND CHARACTERIZE NOVEL VIRUSES CAPABLE OF VERTEBRATE CELL REPLICATION. TWO SPECIFIC AIMS HAVE BEEN DESIGNED TO ACHIEVE THIS GOAL. IN SPECIFIC AIM 1, A DIVERSE RANGE BLOOD-FEEDING ARTHROPODS (TICKS, MIDGES, SANDFLIES, BLACKFLIES, AND FLEAS) WILL BE ASSAYED FOR NOVEL AND PREVIOUSLY RECOGNIZED VIRUSES BY UNBIASED HIGH-THROUGHPUT SEQUENCING (UHTS). THESE EXPERIMENTS WILL BE PERFORMED USING HOMOGENATES ALREADY IN OUR POSSESSION AND PREPARED FROM >37,000 ARTHROPODS FROM NORTH AMERICA. TOTAL RNA WILL BE DIRECTLY EXTRACTED FROM EVERY HOMOGENATE AND VIRAL SEQUENCES WILL BE IDENTIFIED USING UHTS AND AN ESTABLISHED BIOINFORMATICS PIPELINE, ALLOWING THE VIROSPHERE OF THE ARTHROPODS TO BE DEFINED. ADDITIONALLY, THE CODON AND DINUCLEOTIDE FREQUENCIES OF EVERY NOVEL VIRUS WILL BE DETERMINED TO PROVIDE INSIGHT INTO THEIR HOST RANGES AND TO IDENTIFY THOSE MOST LIKELY TO REPLICATE IN VERTEBRATE CELLS. IN THIS REGARD, VERTEBRATES AND INVERTEBRATES PREFERENTIALLY HAVE CERTAIN CODON AND DINUCLEOTIDE USAGE BIASES AND THE PREFERENCES OF RNA VIRUSES OFTEN MIMIC THOSE OF THEIR HOSTS. IN SPECIFIC AIM 2, AN ALIQUOT OF EACH HOMOGENATE WILL BE INOCULATED ONTO HUMAN AND NONHUMAN PRIMATE CELLS THEN TWO BLIND PASSAGES WILL BE PERFORMED. TOTAL RNA WILL BE EXTRACTED FROM ALL FINAL CULTURE PASSAGES AND ANALYZED BY UHTS AND BIOINFORMATICS IN ORDER TO SPECIFICALLY IDENTIFY VERTEBRATE-INFECTING VIRUSES. IF AN ISOLATE IS NOT RECOVERED BUT THE HOMOGENATE IS PREDICTED TO CONTAIN A VERTEBRATE-INFECTING VIRUS, AS DETERMINED IN THE CODON AND DINUCLEOTIDE FREQUENCY ANALYSIS, VIRUS ISOLATION WILL BE ATTEMPTED USING ADDITIONAL VERTEBRATE CELL LINES. THE IN VITRO REPLICATION KINETICS AND YIELDS OF EVERY NOVEL VIRUS CAPABLE OF VERTEBRATE CELL REPLICATION WILL BE DETERMINED. THE STUDIES PROPOSED IN THIS GRANT APPLICATION PROVIDE THE GROUNDWORK FOR FUTURE IN VIVO EXPERIMENTS, WHERE VIRUSES CAPABLE OF VERTEBRATE CELL REPLICATION WILL BE FURTHER CHARACTERIZED. EXPERIMENTAL INFECTIONS WILL BE PERFORMED WITH VERTEBRATE ANIMALS AND ARTHROPODS TO ASSESS VIRAL VIRULENCE AND TO IDENTIFY COMPETENT VECTOR SPECIES, RESPECTIVELY. FUTURE EXPERIMENTS WILL ALSO BE PERFORMED TO DETERMINE THE INCIDENCE AND SEROPREVALENCE OF SELECT VIRUSES IN HUMAN AND VERTEBRATE ANIMAL POPULATIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $76.5k | 4/22/25 | ||
| Not listed | $7.7k | 9/11/24 | ||
| Not listed | $7.7k | 9/11/24 | ||
| Not listed | $68.9k | 6/7/24 | ||
| Not listed | $68.9k | 6/7/24 |